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Abstract: Implants inserted in the posterior maxilla frequently need additional surgery for successful
bone augmentation. One of the most common procedures for this is transalveolar sinus floor elevation.
There are different protocols for this procedure, and there is controversy over the simultaneous
application of grafting material upon elevating. In this prospective randomized clinical study in
humans, a total of 49 transalveolar sinus floor elevations were performed in 49 different patients,
divided into a control group (without graft, 25 patients) and a test group (with graft, 24 patients).
The analyzed variables were obtained through digital orthopantomography on day 0 (day of surgery)
and 18 months after surgery. These measurements showed a tendency towards greater vertical bone
gain in the test group, but this was not statistically significant. Therefore, considering that sinus
elevation and implant placement without the application of grafts is a successful treatment with
fewer complications, a critical assessment of the need for these biomaterials is necessary.
Keywords: osteotome; transalveolar sinus floor elevation; bone grafting
1. Introduction
Since the 1970s, classical longitudinal studies have shown that the first teeth to be lost due to
periodontal disease are the maxillary molars, whose prolonged absence causes a reduced bone volume
due to pneumatization of the maxillary sinus and alveolar bone resorption from the lack of mechanical
stimulation [1–7]. The success of implant therapy is directly related to primary stability, and in turn,
to the bone volume present at the implant site. As a result, the long-term prognosis can be poor due to
the presence of insufficient bone volume [8–12].
The first author to propose a transalveolar approach to correct the pneumatization of the sinus
cavity and place implants was Tatum in 1986 through a “socket former”, which is the same size as the
implant to be placed [13,14]. In 1994, Summers proposed the use of tapered osteotomes with increasing
diameters to conserve more bone when drilling was not carried out. After elevating, autografts,
allografts, xenografts, or synthetic materials were added [15–18].
Int. J. Environ. Res. Public Health 2020, 17, 1888; doi:10.3390/ijerph17061888 www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2020, 17, 1888 2 of 11
Currently, the simultaneous use of grafts for sinus floor elevation in the transalveolar approach
is a subject of controversy. Many authors consider the ‘tent’ effect produced after fracture and
displacement of the cortical bone at the sinus floor allows the formation and stabilization of blood clots
and spontaneous bone formation, this minimizes the risks of introducing material into the sinus [19–21].
The objective of this article is to evaluate whether the use of biomaterials together with the elevation of
the transalveolar sinus floor is justified. This way done by comparing the radiographic vertical bone
gain at 18 months and evaluating the covering at the region apical to the implant.
2. Results
There were not significative differences in baseline values in both groups. Any baseline differences
were less than 0.54 mm in all variables analyzed and without statistical significance (Figure 1).
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as a reference mesially (BM-baseline) (7.98 mm ± 1.35, 95% CI −0.3,1.23, p = 0.263) or distally (BD-
baseline) (7.37 mm ± 1.41, 95% CI −0.39,1.24, p = 0.292). 
Table 1. Bone gain in mm mesially and distally from the alveolar crest border to the sinus floor 
(intercortical) and from the implant neck to the sinus floor. Height of floor elevated mesially, distally, 
and apically to the implant. 
Figure 1. (a) Mean values obtained for the baseline variables analyzed in the radiographic measurements
on the day of surgery (expressed in millimeters). (b,c) Mean values obtained (mm) for the elevation
and intra-si us bone gain variables analyzed in the radiographic measurements after 18 months of
surgery (expressed in millimeters).
In this study, minimum baseline cortical values (AM-baseline) of 6.65 ± 1.32 mm (95% CI −0.36,
1.16, p = 0.299) mesially and 6.03 ± 1.42 mm distally (AD-baseline) (95% CI −0.3,1.23, p = 0.263) were
obtained (Table 1 and Figure 2). There were no statistically significant differences in variables between
the test and control groups. There were also no differences if the implant shoulder was taken as a
reference mesially (BM-baseline) (7.98 mm ± 1.35, 95% CI −0.3,1.23, p = 0.263) or distally (BD-baseline)
(7.37 mm ± 1.41, 95% CI −0.39,1.24, p = 0.292).
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Table 1. Bone gain in mm mesially and distally from the alveolar crest border to the sinus floor
(intercortical) and from the implant neck to the sinus floor. Height of floor elevated mesially, distally,
and apically to the implant.
DISTANCES AT CRESTA
ALVEOLAR LEVEL Gain (mm)
Without
Biomaterial
With
Biomaterial p
Confidence
Interval 95%
intercortical bone, mesial 2.98 3.62 0.001 0.42/1.66
intercortical bone, distal 3.56 4.12 0.005 0.39/1.83
from implant neck to floor, mesial 2.86 3.48 0.001 0.48/1.65
from implant neck to floor, distal soil 3.47 3.94 0.006 0.66/1.54
floor elevation, mesial 3.28 3.47 0.591 * −0.49/0.85
floor elevation, distal 3.70 4.09 0.225 * −0.25/1.02
bone above implant 0.63 1.12 <0.0005 0.27/0.77
* No statistical significance.
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Figure 2. Differences in baseline values between the test and control groups (expressed in millimeters).
These values after the transalveolar elevation technique (global means) were 9.94 mm (±1.18)
for AM-ele ted and 9.86 mm (±1.24) for AD-elevated (Figure 2). Taking the implant shoulder
as a reference, these measurements were 11.14 mm (±1.14) for BM-eleva ed and 11.07 mm (±1.12)
for BD-elevated.
The mean distance from the apex of the implant to the new base of the maxillary sinus (length D)
was 0.87 m (±0.47), with a maximum valu of 1.88 mm (Figure 2). The ‘ ent’ was elevated mesially
by 3.37 mm (±1.15) and distally by 3.89 m (±1.11).
When analysis was carried out by the study group, we found that there was a greater difference
between baseline and elevat values in the test group (with biom terial) compared o the control
group and that this differenc was accentuated in the distal aspect of he implant (Figure 3). Looking
only at the elevated values, this difference was repeate when length CD (the dis ance f om the initial
sinus bas line to the new sinu bas li e in the dist l aspect of the implant), length CM (the distance
from the in tial sinus baseline to the new sinus baseline in the mesial aspect of the implant), an length
D were analyzed. We always saw larger values in th test group, with CD and D being particul rly
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large, but only the latter was statistically significant (Figures 4 and 5). When analyzing the magnitude
of elevation obtained in both groups (subtraction of elevated values from baseline values), it was
evident that in all the analyzed lengths, both mesially (AM-elevated) and distally (AD-elevated), better
results were achieved in the test group (Table 1).
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By individually analyzing all the elevated lengths, in radiographs analyzed 18 months after
implant placement with elevation, we found that all variables had higher values in the group with
biomaterial (Figure 2). T ese alues observed were the highest distal to t e implant. The BD-elevated
length (10.63 mm in the control group and 11.53 mm in t e test group) and the CD length (3.70 mm in
the control group and 4.09 mm in the test) presented the greatest differences (Figures 4 and 5). All the
variables analyzed were normally distributed xcept for BM-baseline, AD- levated, BD-elevated,
and length D. Student’s t-test was used to compar the normally distributed variabl s, this show
statistical significance for all at 18 months (p < 0.005). The four non-normally distributed variables
were compared by th Mann–Whitney U-test for independent samples, and only length D showed
statistically significant differe ces (p < 0.005).
3. Discussion
In this study, all the radiographs are orthopantomographs done with the same orthopantomograph
machine (KaVo Dental GmbH and Co. Biberach, Germany) with vertical magnification that was
calibrated according to the length of the implant placed. For this reason, knowing the magnification
average, we could adjust all measurements and calibrated mathematically.
In this study, we did not do horizontal measurements, which would have been an important
limitation in the study due to orthopantomography distortion.
Summers transalveolar method proposed a crestal approach using tapered osteotomes of increasing
diameters to conserve a larger amount of bone. Since drilling is not done, the adjacent bone is compressed
by pushing and tapping as the sinus membrane is lifted. Next, autografts, xenografts, allografts,
or synthetic materials are added to increase the volume below the elevated sinus membrane.
In our study, we obtained a 100% success rate and survival rate for all implants evaluated.
Rosen et al. [15], in a multicenter study in which 173 implants that were submerged and placed by
this technique were followed up. These implants showed a success rate of 96% at 18 months of
loading [13]. It is thought that this is due to the elevation of the sinus floor with osteotomes combined
with bone grafts (i.e., bone-added osteotome sinus floor elevation) and so is more conservative and
less invasive [13].
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Although the results obtained in this study showed a success rate of 100% for both study groups and
no complications were reported, it is important to note that some authors, such as Nedir et al. [22–24],
in their prospective, randomized, controlled studies, saw a higher complication and a success rate at
90% in the grafted group compared to 94.1% in the control group; this is after 5 years of evaluation.
Any differences in success rates compared to our findings could be due to one of their inclusion criteria
being the residual bone height of ≤4 mm, and while this study obtained baseline means of 6.65 mm
mesially and 6.03 mm distally with the minimum baseline values of 4.17 mm mesially and 3.56 mm
distally. The current scientific literature indicates that, taking into account that bone grafts are placed
blindly in the space below the sinus membrane, there is an increased risk of complications when the
residual alveolar bone height is less than 4 mm.
In our study, the maintenance of the patient in periodontal health was very important, as we
know from the studies carried out by Patini et al. and Martellacci et al. [25,26] that the oral microbiota
can negatively influence the success rates of our implant therapy.
There is controversy about the need to place graft material to maintain space for the formation
of new bone after elevating the sinus membrane using the osteotome technique. Regardless of the
measurement used, we found no inter-group differences in vertical bone gain in either the mesial
or distal aspect of the implants. These results agree with those obtained by Markovic et al. [27] in
their prospective randomized study of a total of 200 implants. They found that all implants achieved
intra-sinus bone filling, which was significantly higher in the graft group in initial measurements.
However, these values were the same after 29.7 months due to the volumetric loss detected in both
groups. Therefore, it can be concluded that the use of biomaterials does not influence implant survival,
nor is it a requirement for future osteogenesis.
Along the same lines, Yang et al. [28] performed a retrospective study on 51 implants by analyzing
the radiographic changes found in the first months. They used implants of similar diameter to ours
(4.5–5 mm) and with lengths of 6–8 mm. The mean intra-sinus new bone formation joining the mesial
and distal aspects in our study was 3.49 mm in the control group and 3.78 mm in the test group.
The values of the test group resemble those obtained by Yang et al. [28] (mean of 3.96 ± 2.38), but
their values in the control group were lower (mean of 1.29 ± 1.07 mm). The authors conclude that
there were no statistically significant differences between the mean length of implant protrusion into
the sinus in the ungrafted group vs. the grafted group after elevation. A recent meta-analysis and
systematic review of the literature by Chen and Shi [29] obtained significant differences in intra-sinus
bone gain between the grafted group (4.1 mm) and the control group (2.9 mm). Their study indicates
that there were no statistically significant differences, but some authors, such as Pjetursson, suggest
that there is a greater probability of bone neoformation when grafts are used, and others, such as with
Nedir et al. [22–24], emphasize that in 100% of graft cases, neoformation is always greater than 2 mm,
compared to 93.8% of cases in the control group.
A recent systematic review and meta-analysis conducted by Aludden et al. [30] showed mean
intra-sinus bone gain similar to those in our study. In the non-graft group, it was 3.2 mm, while in the
group grafted with Bio-Oss®(Geistlich, Switzerland), it was higher. These differences disappeared on
radiography after the first year due to graft contraction. Caban et al. [31] and Nedir et al. [32], both in
studies with a single group without graft material and with 68 and 25 implants, respectively, used
radiographic analysis to demonstrate that the use of a graft was not necessary to obtain intra-sinus bone
gains, as the groups had average gains of 3.2 mm (with a maximum value of 4.6 mm) and 3.14 mm,
respectively. These results are in line with ours (mean gain without grafting of 4.52, maximum of
4.98 mm).
Although the variables analyzed in this study do not seem to clarify the controversy present in
the current literature, the variables analyzed show a slight tendency to be higher in the test group than
in the control group. This may be because, when introducing biomaterials, the Schneider membrane
moves further away from the apex of the implant. For this reason, length D was the only variable
to show statistically significant differences. This variable has not been analyzed by other authors,
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who consider the protrusion of an implant into the sinus as a “zero” space between the apex of the
implant and Schneider membrane.
These slight tendencies are always greater in the measurements performed on the distal aspects
of the placed implants. This may be due to the shape of the sinus (always being more pneumatized
distally), the effect of gravity when blindly introducing the biomaterial (as in sinus lifts with a lateral
window approach), or the residual bony plate being irregular and almost always less in the distal zone.
In this case, since it is a tissue-level implant, and aiming to not leave a treated surface exposed distally,
sometimes the implant is submerged more mesially, causing crestal bone remodeling and decreasing
the dimensions achieved mesial to the implant. The authors mentioned above did not analyze the
possible differences between the mesial and distal aspects of the placed implants.
In the discussion about the degree with we can generalize to the rest of the population the
results of this study, we could highlight that the risk of bias in the selection was eliminated (balanced
randomization has already been discussed, as well as the homogeneity of onset in the residual flanges
of both groups). On the other hand, there is no Hawthorne effect in this technique whereby the subject,
knowing that it is measured, can influence the results.
4. Materials and Methods
4.1. Study Population and Inclusion Criteria
The study was conducted at the School of Health and Sports Sciences of the University of Zaragoza
at the Dental Practice Center. The ethics committee of the University of Zaragoza (CEIC Aragon)
approved this study, as reflected in its Act No. 04/2019.
Patients older than 18 years, with good general health status (American Society of Anesthesiologists
status I or II), who presented partial posterior maxillary edentulism, and who wanted rehabilitation
through dental implants were included. Patients had to have adequate bone thickness for implant
placement (residual bone height of at least 5 mm), and, at the discretion of the physician would require
sinus elevation with osteotomes. All patients were included in a periodontal program, and if required,
were operated on without signs of periodontal disease (when we find bleeding of probing and probing
depth greater or equal than 4 mm.). In this study, implants were only included that were to be placed in
areas where at least 4 months had elapsed after dental extractions and in areas that had not undergone
previous bone regeneration.
The sample size was calculated with the program N Query Advisor, this was based on the study
of Nadir, with 3.9 mm on average for the test group and 5.0 mm for the control group with a common
standard deviation of 1.0 and a statistical power of 80% in a two-tailed study with statistical significance
set at p < 0.05 [22]. According to the established inclusion criteria, a total of 49 patients were selected
(n = 49), they were randomly distributed into two groups:
• Control (implant placement without graft material), n = 25;
• Test (implant placement with graft material), n = 24.
Patients were assigned to the groups randomly. A balanced randomization with 50 letters was
done: 25 controls and 25 tests (we lost a patient because he changed his location). With this method,
we guarantee the homogeneity of both groups, that probably, we could not have reached throwing
a coin.
The calibrated researcher that made the measurements was blind, ignoring the membership of
each group.
4.2. Surgical Procedure
The surgery was performed under aseptic conditions by preparing a sterile surgical field in the
dental operating room. Antibiotic prophylaxis was administered, consisting of 2 g amoxicillin or
600 mg of clindamycin + 500 metronidazole in cases of allergies, 1 h before surgery. Pre-surgical
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patient preparation included oral rinsing with 0.1% chlorhexidine for one minute, followed by buccal
and palatal administration of 40.0 mg articaine hydrochloride with 40/0.005 mg/mL epinephrine for
local anesthesia.
A crestal incision was made with or without releasing, and a full mucoperiosteal flap was lifted.
The optimal three-dimensional positions were chosen via a surgical stent, and drilling was performed
with the pilot drill up to 1.5–2 mm from the sinus floor. Then, the elevation was performed with the
first osteotome, creating a “greenstick” fracture of the sinus floor, progressively increasing the diameter
of each osteotome used until it reached approximately 1.5 mm smaller than the implant diameter to
be placed.
Once elevation was complete, randomized patients received the implant (control group) or were
treated with approximately 0.2–0.3 g of graft material (Bio-Oss®, Geistlich, Switzerland) before implant
placement (experimental group). Previously, clinical verification of the integrity of the Schneiderian
membrane (Valsalva manoeuvre) was performed.
All patients were treated with Klockner Essential Cone®implants (SOADCO S.L., Andorra) with a
standard platform of 4.5 mm, varying the implant diameter between 3.5 and 4.5 mm, depending on the
horizontal available bone (width of the existing ridge), maintaining at least 1.5 mm of bone around the
implant site. All patients received the same postoperative advice, and after surgery, antibiotic treatment
(amoxicillin 750 mg/8 h or clindamycin 300 mg/8 h + metronidazole 250 mg/8 h) and anti-inflammatory
treatment (ibuprofen 600 mg/8 h) was prescribed. Gastric protection consisted of omeprazole capsules
20 mg/24 h.
All patients underwent digital orthopantomography on the day of implant placement.
4.3. Statistical Analysis
The variables analyzed were as follows:
- Initial available bone: Amount of bone measured on a calibrated panoramic radiograph.
- Implant length: The length of the implant used was 8 or 10 mm.
- Postoperative radiography:
Postoperative orthopantomography was done to assess the correct placement of the implant
relative to the adjacent structures and to allow different measurements.
The measurements collected on the day of surgery were as follows:
• Length AM-baseline: Distance between the alveolar process and cortical bone of the sinus floor,
mesial to the implant.
• Length BM-baseline: Distance between the implant shoulder and the cortical bone of the sinus
floor, mesial to the implant.
• Length AD-baseline: Distance between the alveolar process and the cortical bone of the sinus
floor, distal to the implant.
• Length BD-baseline: Distance between the implant shoulder and the cortical bone of the sinus
floor, distal to the implant.
Measurements recorded at 18 months were:
• Length AM-elevated: Distance between the alveolar process and the new sinus cortical bone,
mesial to the implant.
• Length BM-elevated: Distance between the implant shoulder and the new sinus cortical bone,
mesial to the implant.
• Length AD-elevated: Distance between the alveolar process and the new sinus cortical bone,
distal to the implant.
• Length BD-elevated: Distance between the implant shoulder and the new sinus cortical bone,
distal to the implant.
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• Length CM: Distance between the initial sinus cortical bone and the new cortical bone, mesial to
the implant.
• Length CD: Distance between the initial sinus cortical bone and the new cortical bone, distal to
the implant.
• Length D: Distance from the apex of the implant to the new cortical bone.
(Figure 1a–c).
Given that the orthopantomographs can distort the image (i.e., magnify it), the implants were
measured, and the degree of distortion for each variable was calculated before the analysis. Each variable
was measured three times (24 h apart) by the same operator calibrated with a previous kappa of 0.99.
The intraclass correlation coefficient of the three measurements showed a very good correlation, so the
mean of the three measurements was taken for analysis.
Statistical analysis was performed using IBM SPSS Statistics 24 software (IBM, New York, EEUU).
First, statistical data cleansing (exploration) was performed by numerical methods and graphs.
The quantitative variables were summarized as the means and standard deviations. Descriptive
analyses were completed with the corresponding graphical representations. The qualitative variables
were expressed as percentages. Inter-group comparisons were made with Student’s t-test (after
checking for normality with the Shapiro–Wilk test). Those variables that were not normal were
compared with the Mann–Whitney U-test for independent samples. A significance level of p < 0.05
and a confidence interval of 95% was established.
5. Conclusions
Transalveolar sinus elevation is a predictable treatment with or without biomaterials. Although
the values achieved were higher with the use of a biomaterial, there was no statistical or clinical
differences that makes it necessary for transalveolar elevation. Although there were no postsurgical
complications in this study, the use of biomaterials in transalveolar elevations may pose an increased
risk of complications for the patient. Further studies are needed with a longer follow-up and a similar
methodology to verify whether the use of biomaterials could provide better support to the clinical
results achieved.
Author Contributions: A.M.M.: Data Collection/Analysis/Interpretation; Drafting the Article; Approval of the
Article. R.B.Á. Critical Revision of the Article. Concept/Design. M.P.M.: Data Analysis/Interpretation; Critical
Revision of the Article; Approval of the Article. M.G.G.: Data Analysis/Interpretation; Drafting the Article;
Approval of the Article. D.S.G.-M.; Drafting the Article; Approval of the Article. B.R.-C.: Statistics; Approval of
the Article. F.M.: Concept/Design; Statistics; Critical Revision of the Article; Approval of the Article. J.V.R.-S.:
Concept/Design; Statistics; Critical Revision of the Article. A.F.-P. Concept/Design, Statistics. All authors have
read and agreed to the published version of the manuscript.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Axelsson, P.; Lindhe, J. The significance of maintenance care in the treatment of periodontal disease. J. Clin.
Periodontol. 1981, 8, 281–294. [CrossRef] [PubMed]
2. Pihlstrom, B.L.; Oliphant, T.H.; McHugh, R.B. Molar and nonmolar teeth compared over 6 12 years following
two methods of periodontal therapy. J. Periodontol. 1984, 55, 499–504. [CrossRef] [PubMed]
3. Kalkwarf, K.L.; Kaldahl, W.B.; Patil, K.D. Evaluation of furcation region response to periodontal therapy.
J. Periodontol. 1988, 59, 794–804. [CrossRef] [PubMed]
4. Hirschfeld, L.; Wasserman, B. A long-term survey of tooth loss in 600 treated periodontal patients. J. Periodontol.
1978, 49, 225–237. [CrossRef]
5. Frost, H.M. Bone’s mechanostat: A 2003 update. Anat. Rec. 2003, 275, 1081–1101. [CrossRef]
6. Frost, H.M. Bone “mass” and the “mechanostat”: A proposal. Anat. Rec. 1987, 219, 1–9. [CrossRef]
Int. J. Environ. Res. Public Health 2020, 17, 1888 10 of 11
7. Wiskott, H.W.A.; Belser, U.C. Lack of integration of smooth titanium surfaces: A working hypothesis based
on strains generated in the surrounding bone. Clin. Oral Implant. Res. 1999, 10, 429–444. [CrossRef]
8. Misch, C.E. Maxillary sinus augmentation for endosteal implants: Organized alternative treatment plans.
Int. J. Oral Implant.. 1987, 4, 49–58.
9. Jensen, O.T.; Shulman, L.B.; Block, M.S.; Iacono, V.J. Report of the sinus consensus conference of 1996. Int. J.
Oral Maxillofac. Implant. 1998, 13, 11–45.
10. Cardaropoli, G.; Araujo, M.; Lindhe, J. Dynamics of bone tissue formation in tooth extraction sites.
An experimental study in dogs. J. Clin. Periodontol. 2003, 30, 809–818. [CrossRef]
11. Botticelli, D.; Berglundh, T.; Persson, L.G.; Lindhe, J. Bone regeneration at implants with turned or rough
surfaces in self-contained defects. An experimental study in the dog. J. Clin. Periodontol. 2005, 32, 448–455.
[CrossRef] [PubMed]
12. Zarb, G.A.; Zarb, F.L. Tissue integrated dental prostheses. Quintessence Int. 1985, 16, 39–42. [PubMed]
13. Tatum, H. Maxillary and sinus implant reconstructions. Dent. Clin. North Am. 1986, 30, 207–229. [PubMed]
14. Boyne, P.J.; James, R.A. Grafting of the maxillary sinus floor with autogenous marrow and bone. J. Oral Surg.
1980, 38, 613–616.
15. Rosen, P.S.; Summers, R.; Mellado, J.R.; Salkin, L.M.; Shanaman, R.H.; Marks, M.H.; Fugazzotto, P.A.
The bone-added osteotome sinus floor elevation technique: Multicenter retrospective report of consecutively
treated patients. Int. J. Oral Maxillofac. Implant 1999, 14, 853–858.
16. Summers, R.B. A new concept in maxillary implant surgery: The osteotome technique. Compendium 1994, 15,
154–156.
17. Summers, R.B. The osteotome technique: Part 2—The ridge expansion osteotomy (REO) procedure.
Compendium 1994, 15, 422, 424, 426, passim; quiz 436.
18. Summers, R.B. The osteotome technique: Part 3—Less invasive methods of elevating the sinus floor.
Compendium 1994, 15, 694–702.
19. Emmerich, D.; Att, W.; Stappert, C. Sinus floor elevation using osteotomes: A systematic review and
meta-analysis. J. Periodontol. 2005, 76, 1237–1251. [CrossRef]
20. Shalabi, M.M.; Manders, P.; Mulder, J.; Jansen, J.A.; Creugers, N.H. A meta-analysis of clinical studies to
estimate the 4.5-year survival rate of implants placed with the osteotome technique. Int. J. Oral Maxillofac.
Implant. 2007, 22, 110–116.
21. Tong, D.C.; Rioux, K.; Drangsholt, M.; Beirne, O.R. A review of survival rates for implants placed in grafted
maxillary sinuses using meta-analysis. Int. J. Oral Maxillofac. Implant. 1998, 13, 175–182.
22. Nedir, R.; Nurdin, N.; Abi Najm, S.; El Hage, M.; Bischof, M. Short implants placed with or without grafting
into atrophic sinuses: The 5-year results of a prospective randomized controlled study. Clin. Oral Implant.
Res. 2017, 28, 877–886. [CrossRef] [PubMed]
23. Nedir, R.; Nurdin, N.; Khoury, P.; Perneger, T.; Hage, M.E.; Bernard, J.P.; Bischof, M. Osteotome sinus
floor elevation with and without grafting material in the severely atrophic maxilla. A 1-year prospective
randomized controlled study. Clin. Oral Implant. Res. 2013, 24, 1257–1264. [CrossRef] [PubMed]
24. Nedir, R.; Nurdin, N.; Khoury, P.; Bischof, M. Short implants placed with or without grafting in atrophic
sinuses: The 3-year results of a prospective randomized controlled study. Clin. Implant Dent. Relat. Res.
2016, 18, 10–18. [CrossRef] [PubMed]
25. Patini, R.; Gallenzi, P.; Spagnuolo, G.; Cordaro, M.; Cantiani, M.; Amalfitano, A.; Arcovito, A.; Callà, C.;
Mingrone, G.; Nocca, G. Correlation between metabolic syndrome, periodontitis and reactive oxygen species
production. A pilot study. Open Dent. J. 2017, 11, 621–627. [CrossRef] [PubMed]
26. Martellaci, L.; Quaranta, G.; Patini, R.; Isola, G.; Gallenzi, P.; Masucci, L. A literature review of metagenomics
and culturomics of the peri-implant microbiome: Current evidence and future perspectives. Materials 2019,
12, 3010. [CrossRef]
27. Markovic, A.; Misic, T.; Calvo-Guirado, J.L.; Delgado-Ruiz, R.A.; Janjic, B.; Abboud, M. Two-center
prospective, randomized, clinical, and radiographic study comparing osteotome sinus floor elevation with
or without bone graft and simultaneous implant placement. Clin. Implant Dent. Relat. Res. 2016, 18, 873–882.
[CrossRef]
28. Yang, J.; Xia, T.; Fang, J.; Shi, B. Radiological changes associated with new bone formation following osteotome
sinus floor elevation (OSFE): A retrospective study of 40 patients with 18-month follow-up. Med. Sci. Monit.
2018, 24, 4641–4648. [CrossRef]
Int. J. Environ. Res. Public Health 2020, 17, 1888 11 of 11
29. Chen, M.H.; Shi, J.Y. Clinical and radiological outcomes of implants in osteotome sinus floor elevation with
and without grafting: A systematic review and a meta-analysis. J. Prosthodont. 2018, 27, 394–401. [CrossRef]
30. Aludden, H.; Mordenfeld, A.; Hallman, M.; Christensen, A.E.; Starch-Jensen, T. Osteotome-mediated sinus
floor elevation with or without a grafting material: A systematic review and meta-analysis of long-term
studies (>/=5-Years). Implant Dent. 2018, 27, 488–497. [CrossRef]
31. Caban, J.; Fermergard, R.; Abtahi, J. Long-term evaluation of osteotome sinus floor elevation and simultaneous
placement of implants without bone grafts: 10-year radiographic and clinical follow-up. Clin. Implant Dent.
Relat. Res. 2017, 19, 1023–1033. [CrossRef] [PubMed]
32. Nedir, R.; Nurdin, N.; Vazquez, L.; Abi Najm, S.; Bischof, M. Osteotome sinus floor elevation without grafting:
A 10-year prospective study. Clin. Implant Dent. Relat. Res. 2016, 18, 609–617. [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
